Rejuva Fresh® Reveals a New Clinical Study Positioning EMSHAPE® NEO PLUS as the Future Leader in Regenerative Aesthetics
PR Newswire
ELLSWORTH, Maine, Aug. 13, 2025
ELLSWORTH, Maine, Aug. 13, 2025 /PRNewswire/ -- Rejuva Fresh®, a leader in energy-based aesthetic technology, is excited and proud to announce the release of a new clinical study evaluating the company's popular innovation, EMSHAPE NEO PLUS®. The study, published by Dr. Joseph Guinto of the TRXN CHIROPRACTIC CARE FOR ATHLETICS AND INJURY PREVENTION in Orlando, Florida, spotlights the groundbreaking potential of this non-invasive in-office treatment protocol. The clinical study clearly demonstrates that EMSHAPE NEO PLUS not only has the ability to enhance appearance—such as sculpted abs, firmer skin, and a more toned buttocks—but also to solve common health issues like weak pelvic floor control, limited hip mobility, diastasis recti, high stress levels, and irregular sleep patterns.
EMSHAPE NEO PLUS is an excellent example of regenerative medicine and aesthetics due to its ability to stimulate the body's natural processes for muscle building and fat reduction, rather than just addressing superficial concerns. EMSHAPE NEO PLUS employs a combination of ultra-concentrated high-intensity electromagnetic pulses and robust high-frequency radio waves to promote the formation of strong new muscle while naturally enhancing collagen synthesis to combat visible signs of aging.
In this exciting clinical trial, 10 female CrossFit athletes in their early thirties underwent a treatment regimen that included pelvic floor strengthening, functional core retraining, and instruction on managing intra-abdominal pressure.
Renowned board-certified chiropractor Dr. Joey Guinto conducted the clinical trial, which yielded highly positive outcomes. The study utilized the FDA-cleared EMSHAPE NEO PLUS device, distinguished by its high maximum magnetic density per applicator, optimized radio frequency, and a broad electromagnetic pulse frequency range.
The study involved 10 women in their early thirties who were professional athletes, mothers of one or more children, had undergone no previous pelvic floor rehabilitation, and were otherwise healthy and active. Before joining the study, these female athletes all experienced challenges, which included urine leakage during exercises such as double-unders, box jumps, and heavy lifting, which in turn caused significant embarrassment and even led them to contemplate withdrawing from competition all together.
The therapy protocol in the clinical trial consisted of two sessions per week over four weeks, totaling eight sessions. The electromagnetic intensity of EMSHAPE NEO PLUS was gradually increased to 100% by the third session. Additionally, diaphragmatic breathing and clinical cueing played a crucial role in the study.
Results: On average, patients achieved an 80% reduction in urine leakage by the sixth session. By week four, all participants had resumed full workout routines, with significant improvements in confidence and overall quality of life.
Additional notes: In conclusion, EMSHAPE NEO PLUS serves as a non-invasive bridge to regaining neuromuscular control. All athletes in the study maintained high compliance due to rapid results.
"One thing that sets EMSHAPE NEO PLUS apart is its ability to penetrate deeper than other electromagnetic wave systems on the market and combine two gold-standard technologies—HICMMT and DEEP STRETCH radiofrequency—into a single, efficient treatment protocol," said Dr. Guinto. "This is not only more streamlined for practices—it's a game-changer for patients. We can now proactively enhance, tone, and firm both core and pelvic muscles, while radio frequency-driven collagen stimulation supports skin regeneration. Unlike conventional treatments that focus solely on fat reduction or skin tightening, EMSHAPE NEO PLUS offers comprehensive muscle rehabilitation, making it a more complete solution."
With its unique and advanced dual-energy design, EMSHAPE NEO PLUS is setting a new benchmark in the treatment of various conditions. Dr. Guinto and Rejuva Fresh are in complete agreement that this clinical study has showcased the power of EMSHAPE NEO PLUS, and both parties are very excited.
Indeed, EMSHAPE NEO PLUS delivers a comprehensive, highly effective approach by simultaneously targeting wellness, health, and aesthetics. This solution can reduce reliance on multiple devices while promoting sustained body health and preventing aging. According to Rejuva Fresh Client Relations Manager Kevin Lee, "Many clinics and spas report to us that EMSHAPE NEO PLUS is by far their most in-demand non-invasive device service offering. Some also say that all they really need these days is EMSHAPE NEO PLUS."
"We created EMSHAPE NEO PLUS to simplify and elevate the way practices approach both body sculpting, skin rejuvenation, muscle rehabilitation, and overall quality of life," said Huapei Cai, President and General Manager of Rejuva Fresh LLC Asia Pacific. The most striking benefit for patients is how EMSHAPE NEO PLUS ushers in a new era of proactive care. It empowers individuals to effectively tackle issues such as weak core and pelvic muscles, muscle loss from weight changes or illness, postpartum diastasis recti, urinary incontinence, sexual dysfunction, athletic injuries, and more—while preventing these conditions from worsening. This innovative treatment has the remarkable ability to fully restore physical vitality. Beyond that, EMSHAPE NEO PLUS offers a powerful way to stay ahead of aging, helping maintain a strong, healthy body and youthful skin with fewer sessions and faster results. It's the perfect combination of precision, performance, and prevention—all in one solution.
As wellness plays a growing role in modern aesthetic care, Rejuva Fresh is dedicated to providing practices with clinically proven, highly effective technologies that prioritize patient safety and satisfaction. "At Rejuva Fresh, we are committed to empowering providers with the essential tools to achieve remarkable results," said Polly Jacobs, CEO of Rejuva Fresh. "The launch of EMSHAPE NEO PLUS, coupled with the release of this clinical study, reinforces our dedication to developing technologies that improve patient outcomes and ensure the sustained success of our clients. We are committed to ongoing investment in innovative, effective solutions that address the evolving needs of modern care."
About Rejuva Fresh, LLC.
Rejuva Fresh® is a leading aesthetic equipment developer based in the United States and prioritizes offering powerful state-of-the-art technology combined with top-notch customer support. One of the fastest-growing companies in the aesthetic device industry, Rejuva Fresh offers a wide selection of FDA-cleared systems that address nearly every non-invasive aesthetic and wellness need. Rejuva Fresh's product portfolio provides significant competitive advantages for practices and patients, thanks to their independent business model and strong partnerships with top factories worldwide. Invest in Rejuva Fresh scientifically developed devices, and get comprehensive support from industry experts to achieve optimal clinical results and maximize your return on investment.
For more information, visit: www.rejuvafresh.com.
Media Contact:
Ericson Estrada
hello@rejuvafresh.com
1-888-436-3120
View original content to download multimedia:https://www.prnewswire.com/news-releases/rejuva-fresh-reveals-a-new-clinical-study-positioning-emshape-neo-plus-as-the-future-leader-in-regenerative-aesthetics-302529260.html
SOURCE Rejuva Fresh
